Acetylcholinesterase inhibitor. It might be considered in the POTS phenotype associated with suspected autonomic neuropathy, gastrointestinal dysfunction, and non-specific muscle weakness. The effect on BP is small. This evidence concerns the gene ACHE and autonomic neuropathy.